(Q40806556)

23 September 2017

title

Proteoglycans decorin and biglycan differentially modulate TGF-beta-mediated fibrotic responses in the lung (English)

1 reference

23 September 2017

Kolb M

1

1 reference

23 September 2017

Margetts PJ

series ordinal

2

1 reference

23 September 2017

Sime PJ

series ordinal

3

1 reference

23 September 2017

Gauldie J

series ordinal

4

1 reference

23 September 2017

publication date

1 June 2001

1 reference

American Journal of Physiology - Lung Cellular and Molecular Physiology

23 September 2017

published in

1 reference

23 September 2017

volume

280

1 reference

23 September 2017

issue

6

1 reference

23 September 2017

page(s)

L1327-34

1 reference

An efficient and flexible system for construction of adenovirus vectors with insertions or deletions in early regions 1 and 3.

23 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.2001.280.6.L1327

Expression and localization of the two small proteoglycans biglycan and decorin in developing human skeletal and non-skeletal tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.2001.280.6.L1327

Pulmonary fibrosis: cytokines in the balance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.2001.280.6.L1327

Targeted disruption of decorin leads to abnormal collagen fibril morphology and skin fragility

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.2001.280.6.L1327

Antifibrotic effect of decorin in a bleomycin hamster model of lung fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.2001.280.6.L1327

Effect of antibody to transforming growth factor beta on bleomycin induced accumulation of lung collagen in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.2001.280.6.L1327

Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.2001.280.6.L1327

Matrix proteoglycans: from molecular design to cellular function

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.2001.280.6.L1327

Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.2001.280.6.L1327

Betaglycan has multiple binding sites for transforming growth factor-beta 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.2001.280.6.L1327

Interstitial fibrosis and growth factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.2001.280.6.L1327

NHLBI Workshop Summary. Pharmacological therapy for idiopathic pulmonary fibrosis. Past, present, and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.2001.280.6.L1327

Interaction of biglycan with type I collagen

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.2001.280.6.L1327

Adenovector-mediated gene transfer of active transforming growth factor-beta1 induces prolonged severe fibrosis in rat lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.2001.280.6.L1327

Negative regulation of transforming growth factor-beta by the proteoglycan decorin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.2001.280.6.L1327

Suppression of experimental glomerulonephritis by antiserum against transforming growth factor β1

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.2001.280.6.L1327

10.1152/AJPLUNG.2001.280.6.L1327

21 January 2018

Identifiers

DOI

0 references

1 reference